The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,456.00
Bid: 14,460.00
Ask: 9,640.00
Change: -594.00 (-4.93%)
Spread: -4,820.00 (-33.333%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: JPMorgan Raises Man Group And Sanne

Thu, 10th Dec 2020 10:16

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

----------

FTSE 100

----------

BERENBERG RAISES CRODA INTERNATIONAL TO 'BUY' ('HOLD') - TARGET 7,200 (6,000) PENCE

----------

MORGAN STANLEY CUTS AVAST PRICE TARGET TO 610 (650) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES VODAFONE PRICE TARGET TO 205 (200) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES RIO TINTO PRICE TARGET TO 5,200 (4,290) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY RAISES GLENCORE PRICE TARGET TO 274 (215) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES EVRAZ PRICE TARGET TO 430 (410) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY RAISES BHP GROUP PRICE TARGET TO 1,960 (1,680) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES ANTOFAGASTA TARGET TO 1,305 (1,030) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY RAISES ANGLO AMERICAN TARGET TO 2,780 (2,280) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES SAGE GROUP TO 'EQUAL-WEIGHT' ('UNDERWEIGHT') - TARGET 610 PENCE

----------

JPMORGAN RAISES DS SMITH PRICE TARGET TO 408 (340) PENCE - 'OVERWEIGHT'

----------

DEUTSCHE BANK RAISES ASHTEAD GROUP PRICE TARGET TO 3,000 (2,150) PENCE - 'HOLD'

----------

BERENBERG RAISES POLYMETAL PRICE TARGET TO 2,580 (2,560) PENCE - 'BUY'

----------

GOLDMAN SACHS RAISES RIO TINTO PRICE TARGET TO 5,645 (4,685) PENCE - 'NEUTRAL'

----------

GOLDMAN RAISES BHP GROUP PRICE TARGET TO 2,360 (2,020) PENCE - 'BUY'

----------

JPMORGAN RAISES STANDARD LIFE ABERDEEN TARGET TO 315 (270) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES SCHRODERS PRICE TARGET TO 3,175 (2,800) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES INTERMEDIATE CAPITAL TARGET TO 2,000 (1,950) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS HARGREAVES LANSDOWN TARGET TO 1,390 (1,470) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN CUTS BUNZL TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 2,800 PENCE

----------

JEFFERIES RAISES ASTRAZENECA PRICE TARGET TO 8,500 (8,100) PENCE - 'HOLD'

----------

FTSE 250

----------

JPMORGAN RAISES SANNE GROUP TO 'OVERWEIGHT' ('NEUTRAL') - TARGET 670 PENCE

----------

JPMORGAN RAISES MAN GROUP TO 'OVERWEIGHT' ('NEUTRAL') - TARGET 150 (140) PENCE

----------

UBS RAISES VICTREX PRICE TARGET TO 1,750 (1,625) PENCE - 'SELL'

----------

MORGAN STANLEY CUTS CENTAMIN PRICE TARGET TO 125 (130) PENCE - 'EQUAL-WEIGHT'

----------

JPMORGAN RAISES INCHCAPE PRICE TARGET TO 708 (645) PENCE - 'OVERWEIGHT'

----------

BERENBERG CUTS WORKSPACE GROUP TO 'SELL' ('HOLD') - TARGET 670 (590) PENCE

----------

BARCLAYS RAISES VICTREX TO 'EQUAL WEIGHT' ('UNDERWEIGHT') - TARGET 1,980 (1,710) PENCE

----------

BARCLAYS CUTS SERCO GROUP PRICE TARGET TO 150 (165) PENCE - 'OVERWEIGHT'

----------

GOLDMAN RAISES BABCOCK INTERNATIONAL TARGET TO 290 (255) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES QUILTER PRICE TARGET TO 180 (170) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES JUPITER FUND PRICE TARGET TO 310 (300) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES ASHMORE GROUP PRICE TARGET TO 385 (360) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN RAISES HOWDEN JOINERY GROUP TARGET TO 677 (641) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS SERCO GROUP PRICE TARGET TO 170 (180) PENCE - 'OVERWEIGHT'

----------

OTHER MAIN MARKET AND AIM

----------

BERENBERG RAISES CERES POWER PRICE TARGET TO 1220 (1060) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES STAGECOACH PRICE TARGET TO 86 (72) PENCE - 'BUY'

----------

BERENBERG CUTS PETRA DIAMONDS PRICE TARGET TO 2 (3) PENCE - 'HOLD'

----------

BERENBERG RAISES GRIFFIN MINING PRICE TARGET TO 115 (105) PENCE - 'BUY'

----------

BERENBERG RAISES GEM DIAMONDS PRICE TARGET TO 51 (43) PENCE - 'BUY'

----------

BERENBERG RAISES CENTRAL ASIA METALS PRICE TARGET TO 250 (234) PENCE - 'BUY'

----------

BERENBERG CUTS ANGLO PACIFIC GROUP PRICE TARGET TO 140 (150) PENCE - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.